Management



CEO
Lawrence Helson BSci, B.MSci., M.Sci., M.D., FAAP
Academic : Peer reviewed publications >190, issued patents 3, pending 4
Institutions: Memorial Sloan Kettering Cancer Center (MSKCC), Cornell University School of Medicine (1967-1986) New York Medical College(1988-1997)
Commercial: Imperial Chemical Industries, (Astra-Zenica)(1986-1987)
Natural Product Biotherapeutics, Inc (NAPRO)1992-2005
Onconova, Inc. 1997-1998 CMO, Hemobiotech Inc. Consultant, Sign Path Pharma, CEO and President Inc. 2007-present
Marketed Products: Zoladex, Taxol
Laboratory Director: Pediatric Neuro-Cancer Research (MSKCC 1973-1986), Cancer Research, New York Medical College (1988-1997), NAPRO R & D (1998 -2005)